Sumitomo Pharma Co Ltd
XMUN:DPM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sumitomo Pharma Co Ltd
XMUN:DPM
|
JP |
|
N
|
Nomura Real Estate Master Fund Inc
F:8BQ
|
JP |
|
S
|
Sumitomo Pharma Co Ltd
F:DPM
|
JP |
|
Telecom Italia SpA
F:TQI
|
IT |
|
C
|
Ceres Power Holdings PLC
F:CFJA
|
UK |
|
M
|
MOL Magyar Olajes Gazipari Nyrt
PSE:MOL
|
HU |
|
B
|
Basler AG
XMUN:BSL
|
DE |
|
B
|
Basler AG
DUS:BSL
|
DE |
|
T
|
Triplepoint Venture Growth BDC Corp
F:6JS
|
US |
|
N
|
NeuroMetrix Inc
F:NLZ
|
US |
|
Freshworks Inc
F:7DF
|
US |
|
LiveOne Inc
F:351
|
US |
|
Carel Industries SpA
F:CIG
|
IT |
|
Polar Power Inc
F:PPW
|
US |
|
A
|
Admiral Group PLC
F:FLN
|
UK |
|
S
|
Serco Group PLC
XMUN:SEO
|
UK |
Wall St Price Targets
DPM Price Targets Summary
Sumitomo Pharma Co Ltd
According to Wall Street analysts, the average 1-year price target for DPM is 11.425 EUR with a low forecast of 8.145 EUR and a high forecast of 15.243 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DPM's stock price target?
Price Target
11.425
EUR
According to Wall Street analysts, the average 1-year price target for DPM is 11.425 EUR with a low forecast of 8.145 EUR and a high forecast of 15.243 EUR.
What is the Revenue forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-26%
Over the last 13 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 2 years is -26%.
What is the Pre-Tax Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
84%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 84%.
What is the Net Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
48%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 48%.
